12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Baudax Bio (NASDAQ:BXRX) shares increased by 130.7% to $1.2 during Friday’s regular session. Trading volume for this…
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms.
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Renalytix (NASDAQ:RNLX) shares moved upwards by 38.6% to $2.87 during Friday’s pre-market session. The company’s market cap…
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Sigilon Therapeutics (NASDAQ:SGTX) stock increased by 657.8% to $29.78 during Thursday’s pre-market session. The company’s market cap…
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
Gainers
Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday.
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Theriva Biologics (AMEX:TOVX) shares moved upwards by 45.0% to $1.2 during Wednesday’s pre-market session. The market value…
Why Theriva Biologics Are Trading Higher By Over 76%; Here Are 20 Stocks Moving Premarket
Gainers
Theriva Biologics, Inc. (NYSE: TOVX) shares surged 76.4% to $1.46 in pre-market trading after the company said Orphan Drug Designation was granted by the U.S. Food and Drug Administration for VCN-01 for the treatment of pancreatic cancer.
